NEW YORK (

TheStreet

) -- Shares of

Theragenics Corporation

(NYSE:

TGX

) have taken a tremendous swing upward. The stock is trading at $2.07 as of 12:47 p.m. ET, 30.2% above Wednesday's closing price of $1.59. Volume is at 580,235, 6.9 times the daily average of 83,800.

Theragenics has a market cap of $53.5 million and is part of the

health care

sector and

health services

industry. Shares are up 6% year to date as of the close of trading on Wednesday.

Theragenics Corporation operates as a medical device company serving the cancer treatment and surgical markets primarily in the United States and Europe. It operates through two segments, Surgical Products and Brachytherapy Seed. The company has a P/E ratio of 26.5, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 15.9.

TheStreet Ratings rates Theragenics as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income and disappointing return on equity. You can view the full

Theragenics Ratings Report

.

See our

top % gaining stocks list

for other stocks that are soaring today, or get investment ideas from our

investment research center

.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting

SOAR

to 95370 or select from

multiple alert options

.

null